Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

Summary background: Multidrug-resistant (MDR) tuberculosis (TB) poses an important challenge in TB management and control. Rifampicin resistance (RR) is a solid surrogate marker of MDR-TB. We investigated the RR-TB clustering rates, bacterial population dynamics to infer transmission dynamics, and t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jean Claude S. Ngabonziza, Leen Rigouts, Gabriela Torrea, Tom Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves M. Habimana, Lies Laenen, Belamo E. Niyigena, Cécile Uwizeye, Bertin Ushizimpumu, Wim Mulders, Emil Ivan, Oren Tzfadia, Claude Mambo Muvunyi, Patrick Migambi, Emmanuel Andre, Jean Baptiste Mazarati, Dissou Affolabi, Alaine N. Umubyeyi, Sabin Nsanzimana, Françoise Portaels, Michel Gasana, Bouke C. de Jong, Conor J. Meehan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-05-01
coleção:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Assuntos:	Tuberculosis in Rwanda Rifampicin-resistant tuberculosis control Universal drug-susceptibility testing Mycobacterium tubercuslosis transmission
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2405579422000043
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!